Posted by Michael Wonder on 24 Jun 2020
US painkiller to be sold in Australian pharmacies to shore up supply
25 June 2020 - Global pharmaceutical giant Johnson & Johnson has been given approval to sell its US painkiller brand Tylenol in Australian pharmacies after a surge in demand for paracetamol during the coronavirus caused supply concerns.
The Therapeutic Goods Administration (TGA) recently gave the local arm of Johnson & Johnson the approval to bring in a range of Tylenol 500mg tablet packets and infant liquid formulas until April 2021.
The TGA can give companies permission to import drugs that are not listed on the Australian Register of Therapeutic Goods (ARTG) when there is a shortage of other similar products registered in Australia. Tylenol is used for pain relief for headaches, cold and flu and fever.
